Belatacept and Sirolimus Prolong Nonhuman Primate Islet Allograft Survival: Adverse Consequences of Concomitant Alefacept Therapy
Author:
Affiliation:
1. Emory Transplant Center, Emory University; Atlanta; GA
2. Yerkes National Primate Research Center; Atlanta; GA
Publisher
Wiley
Subject
Pharmacology (medical),Transplantation,Immunology and Allergy
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-6143.2012.04341.x/fullpdf
Reference21 articles.
1. Transplantation of cultured islets from two-layer preserved pancreases in type 1 diabetes with anti-CD3 antibody;Hering;Am J Transplant,2004
2. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen;Shapiro;N Engl J Med,2000
3. Experience with a novel efalizumab-based immunosuppressive regimen to facilitate single donor islet cell transplantation;Turgeon;Am J Transplant,2010
4. Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes;Hering;JAMA,2005
5. Islet transplantation with alemtuzumab induction and calcineurin-free maintenance immunosuppression results in improved short- and long-term outcomes;Froud;Transplantation,2008
Cited by 43 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Immune checkpoint modulators in early clinical development for the treatment of type 1 diabetes;Expert Opinion on Investigational Drugs;2024-03-13
2. Advances in the Use of Biologics and Biomaterials toward the Improvement of Pancreatic Islet Graft Survival in Type 1 Diabetes;Advanced NanoBiomed Research;2024-01-30
3. Future-directed studies on immunosuppressive treatments and xenografts for organ transplantation;Annals of Liver Transplantation;2022-05-31
4. Designing biomaterials for the modulation of allogeneic and autoimmune responses to cellular implants in Type 1 Diabetes;Acta Biomaterialia;2021-10
5. Microvascular inflammation is a risk factor in kidney transplant recipients with very late conversion from calcineurin inhibitor-based regimens to belatacept;BMC Nephrology;2020-08-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3